Search results
Found 19846 matches for
We lead multidisciplinary applied research and training to rethink the way health care is delivered in general practice and across the community.
An online programme to reduce meat intake
4 March 2022
A bespoke website to support people to eat less meat helped frequent meat eaters to halve their meat consumption over just nine weeks. The trial, run by researchers in the Livestock, Environment and People (LEAP) programme at the University of Oxford, found the programme to be popular with participants who felt it supported them to change their dietary habits. The work is published in the European Journal of Nutrition.
New NIHR Senior Investigator appointed in NDPCHS
3 March 2022
Professor Julia Hippisley-Cox joins the NIHR college of senior research leaders
Oxford-led research makes BJGP's top ten most read and published research articles of 2021
- Awards & appointments
- Digital health & innovation
- Health Services Research
- Patient experience
- QResearch
15 February 2022
Four articles, led or co-authored by Oxford researchers in the department, make the BMJ's top 10 list for the most read and published articles of 2021.
In helping smokers quit, combining treatments is key
10 February 2022
A new clinical review provides guidance to physicians and the public about the most effective tobacco cessation treatments.
Expanding meat-free offering can reduce meat purchases: an observational study
31 January 2022
Boosting the number of plant-based options can be an effective way of encouraging people to choose them and reducing meat purchase and consumption. New research finds that increasing the ratio of meat-free to meat-based meals in canteens could be a simple intervention to promote more sustainable food purchases, and is published in the International Journal of Behavioral Nutrition and Physical Activity.
COVID-19 infection more likely than vaccines to cause rare cardiovascular complications
16 December 2021
Led by the University of Oxford, a team of UK-based researchers have today reported results of the largest ever study to compare the risks of cardiovascular events, such as myocarditis, pericarditis, and cardiac arrhythmia, between different vaccines and COVID-19 infection, and the first to investigate the association between cardiac events and the Oxford-AstraZeneca vaccine.
Recruitment begins for national community COVID-19 antiviral trial
8 December 2021
Researchers from the University of Oxford have today started recruiting participants for a first-of-its-kind clinical trial to test novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 and those who are at higher risk of complications – partnering with the National Institute for Health Research (NIHR) and working with colleagues in several UK universities, and the NHS UK-wide.
Three out of four people with heart failure could be diagnosed sooner, potentially improving quality of life and reducing costs to the healthcare system.
29 November 2021
Researchers from the University of Oxford have today reported that only 1 in 4 people diagnosed with heart failure received a simple, recommended blood test that could have resulted in an earlier diagnosis at a more treatable stage.
Designing and implementing an educational framework for paramedics rotating into primary care
18 November 2021
Georgette Eaton shares an overview of her research as part of her NIHR Doctoral Research Fellowship focusing on the employment of paramedics in primary care.
Department Researchers work highlighted at NCRI festival: Fewer cases of children’s cancer picked up during COVID pandemic
12 November 2021
A study of cancer in children and young adults in England has found that fewer patients were diagnosed during the COVID-19 pandemic. The research, presented at the NCRI Festival, also shows that children who were diagnosed with cancer during the first wave of the pandemic were more likely to have been admitted to intensive care prior to their diagnosis.
Department Researchers work highlighted at NCRI festival: New symptoms identified that could help doctors diagnose pancreatic cancer
8 November 2021
Researchers have identified a series of symptoms associated with pancreatic cancer, including two previously unrecognised symptoms – feeling thirsty and having dark urine – in a study presented today (Monday, 8th Jan) at the NCRI Festival.
PCR cycle threshold may be key to predicting infectiousness of people with asymptomatic and pre-symptomatic COVID-19, suggests new review.
1 November 2021
An international team of researchers, led from Centre for Evidence-based Medicine based in the Nuffield Department of Primary Care Health Sciences, University of Oxford, and funded by the World Health Organization and the National Institute for Health Research School for Primary Care Research, have today announced the findings from the most complete analysis of high-quality covid transmission studies in asymptomatic and pre-symptomatic people to date.
Department awarded funding to complete community COVID-19 antiviral trial
26 October 2021
Researchers from the Nuffield Department of Primary Care Health Sciences, University of Oxford, have today announced that they have been awarded funding through the National Institute for Health Research (NIHR) to work with several UK universities and carry out a first-of-its-kind clinical trial, testing novel antiviral COVID-19 treatments for use early on in the illness by people in the community with COVID-19 who are at higher risk of complications.
COVID-19 infection has greater risk of causing very rare neurological events than vaccines
25 October 2021
Researchers from across the UK, led by the University of Oxford, have today reported on the risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
Professor Trish Greenhalgh elected as new member of the National Academy of Medicine (NAM)
21 October 2021
On Monday, the National Academy of Medicine (NAM) announced the election of 90 regular members and 10 international members during its annual meeting, including our department's very own Trish Greenhalgh. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
Pancreatic cancer early detection funds awarded to department researchers
19 October 2021
Dr Pui San Tan and Professor Julia Hippisley-Cox receive a Research Innovation Award from Pancreatic Cancer UK to develop a risk tool to predict pancreatic cancer in patients with diabetes.
Department led Covid research partnership wins national computing innovation award
11 October 2021
A collaboration which used anonymised GP records to identify 1.5m people most at risk from Covid-19 and prioritise them for vaccination has won the prestigious John Perry Prize for computing innovation in primary care.
Reduction in UK red and processed meat intake, but more needed to meet our climate targets
8 October 2021
Daily meat consumption in the UK has decreased by approximately 17.4g per person per day – just under a 17% reduction – in the last decade finds new research from the University of Oxford. Between 2008/09 and 2018/19 people in the UK reduced both the amount of red and processed meat they eat, while slightly increasing their white meat consumption. Yet, this reduction is significantly less than the 30% reduction the National Food Strategy has recently called for within the next ten years.
Congratulations to Professor Trish Greenhalgh on receiving Highly Commended O2RB Excellence in Impact Award 2021!
6 October 2021
Professor of Primary Care Health Sciences, Trish Greenhalgh, is one of six outstanding Oxford researchers, highly commended for significant contribution to policy discussions and public understanding of COVID-19 precautions internationally, in the O2RB Excellence in Impact Awards 2021.
Hormone therapy not linked to increased risk of developing dementia
30 September 2021
Use of menopausal hormone therapy (MHT), also known as hormone replacement therapy, HRT) is not associated with an increased risk of developing dementia, regardless of hormone type, dose, or duration, conclude a team of researchers from across the UK.